Ondansetron ODT 4 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB25FY8LJ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $6,475
Award facts
- Contract value 100% obligated
- $6,475.18 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $6,475.18 delivery order to AmerisourceBergen Drug Corp for Ondansetron ODT 4 mg tablets (30-count supply) on July 28, 2025, with completion targeted for July 29, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026.
The delivery order for this anti-nausea medication supports the Defense Health Agency's pharmaceutical supply chain and military healthcare operations. AmerisourceBergen's comprehensive IDC with DLA enables the company to supply a broad range of generic and brand-name medications, vaccines, and medical supplies to support military personnel and veteran healthcare systems globally. This specific delivery order reflects the vendor's role as a critical pharmaceutical distributor within the federal medical procurement framework, fulfilling the Defense Logistics Agency's ongoing need for essential pharmaceutical commodities across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FY8LJ?
SPE2DB25FY8LJ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 28, 2025.
How much is contract SPE2DB25FY8LJ worth?
The government has obligated $6,475 on SPE2DB25FY8LJ.
Is contract SPE2DB25FY8LJ an order under another contract?
Yes. SPE2DB25FY8LJ is a delivery order under SPE2DB22D3301, an indefinite delivery contract.
Was contract SPE2DB25FY8LJ competed?
The extent of competition for SPE2DB25FY8LJ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award